Dagmar Aimová

579 total citations
13 papers, 516 citations indexed

About

Dagmar Aimová is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Dagmar Aimová has authored 13 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Dagmar Aimová's work include Cancer therapeutics and mechanisms (10 papers), Lung Cancer Research Studies (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Dagmar Aimová is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Lung Cancer Research Studies (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Dagmar Aimová collaborates with scholars based in Czechia, Germany and United Kingdom. Dagmar Aimová's co-authors include Marie Stiborová, Eva Frei, Manfred Wießler, Jitka Poljaková, Jiřı́ Hudeček, Lucie Bořek-Dohalská, Andrea Breuer, Volker M. Arlt, C. Roland Wolf and Kristina Forsterová and has published in prestigious journals such as Cancer Research, International Journal of Cancer and Carcinogenesis.

In The Last Decade

Dagmar Aimová

13 papers receiving 507 citations

Peers

Dagmar Aimová
Comparison fields: 5 of 63
  • Molecular Biology 359
  • Pharmacology 213
  • Oncology 209
  • Cancer Research 92
  • Organic Chemistry 56
Replace Lucie Bořek-Dohalská with:
Lucie Bořek-Dohalská Czechia
Michaela Moserová Czechia
Y. R. Santosh Laxmi United States
Indra Dwivedy India
Deanne M. Dulik United States
Chitra Mani United States
Mark A. Montoya United States
Wendy Burgess Australia
A. Gescher United Kingdom
Sidney D. Nelson United States
Lucie Bořek-Dohalská Czechia View profile →
Citations per field, relative to Dagmar Aimová
Dagmar Aimová · 1×
Citations per year, relative to Dagmar Aimová
Dagmar Aimová · 1×

Countries citing papers authored by Dagmar Aimová

Since Specialization
Citations

This map shows the geographic impact of Dagmar Aimová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Aimová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Aimová more than expected).

Fields of papers citing papers by Dagmar Aimová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Aimová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Aimová. The network helps show where Dagmar Aimová may publish in the future.

Co-authorship network of co-authors of Dagmar Aimová

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Aimová. A scholar is included among the top collaborators of Dagmar Aimová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Aimová. Dagmar Aimová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
# Work Indexed citations
1 25
2 18
3 9
4 36
5 29
6 33
7 122
8 1
9
Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.
32
10
Cytochromes P450 reconstituted with NADPH: P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes.
12
11 17
12 113
13 69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026